You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

  • Technology appraisal guidance
  • Reference number: TA209
  • Published:  24 November 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation
16 September 2010
(152.23 Kb 44 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 13 September 2010

Back to top